Angion Alternatives & Competitors
12 companies similar to Angion — Angion is committed to transforming the treatment paradigm for patients sufferin...
Companies similar to Angion
Molecure
Fate can be altered.
Warsaw, Poland
Kinarus Therapeutics
Kinarus Therapeutics is a clinical-stage company developing therapies for viral, respirato...
Basel, Switzerland
Promedior
Pioneering advanced therapies to heal fibrotic and inflammatory diseases at their source,...
Pathalys Pharma
Our mission is to improve the lives of patients through enhanced therapeutics to advance t...
Raleigh, United States
Track all Angion competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Minneapolis, United State...
AM-Pharma
AM-Pharma’s ilofotase alfa is being developed as potential enzyme replacement therapy for...
Utrecht, The Netherlands
Wren Therapeutics
Stopping the wave of neurodegeneration at its source
Cambridge, United Kingdom
Sling Therapeutics
Focused on late-stage development of an oral small molecule for the treatment of thyroid e...
Ann Arbor, United States
Madrigal Pharmaceuticals
Madrigal is focused on delivering novel therapeutics for MASH, a serious liver disease.
Conshohocken, United Stat...
-(ACHFF:OTCQB)-logo.jpg "Arch Biopartners Inc (ARCH:TSXV) (ACHFF:OTCQB)"){kind=logo}
Arch Biopartners Inc (ARCH:TSXV) (ACHFF:OTCQB)
A late stage clinical trial company focused on the development of novel therapeutics targe...
Toronto, Canada
Nuevocor
Pioneering novel therapies for untreatable cardiac diseases
Singapore, Singapore
AZTherapies
Targeting Neuroinflammation: The Common Thread of Neurodegenerative Disease Progression
Boston, United States
About Angion
Angion is a late-stage biopharmaceutical company committed to transforming the treatment paradigm for patients suffering from fibrotic diseases. Established in 1998 and headquartered in the United States, Angion focuses on the discovery, development, and commercialization of novel small molecule therapeutics to address...
Biopharmaceutical Company, Drug Discovery, Organ Restoration, Renal Disease, Fibrotic Diseases, Acute Organ Injuries, Small Molecule Therapeutics, Clinical-stage, Delayed Graft Function, Acute Kidney Injury, Cardiopulmonary Bypass, Phase 3, Phase 2, Late-stage, Patient Treatment Paradigm
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Angion and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Angion on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
